FOR CLINICIANS, HOSPITALS & TRIAL SPONSORS

Before changing the drug,
see the dose history.

Patient-reported adherence leaves a missing layer.
Gyroscopic tilt-sensed dispensing records bring a physical-action signal into clinical review—not just a dismissed reminder.

Discuss a partnership
MED-eCARE / CLINICAL WORKSPACEILLUSTRATIVE DATA
DISPENSING WINDOWS MET86%

Tilt detected in 6 of 7 windows

MISSED WINDOW01

Wednesday · 08:00–08:30

REVIEW STATUS

Adherence context available

A CLEARER LAYER OF EVIDENCE

One record.
Multiple care settings.

Remote care, with timing in view.

Review timestamped, sensor-detected dispensing actions alongside blood pressure and glucose readings. Identify missed windows before interpreting an apparent treatment failure; the signal does not prove ingestion.

  • Chronic-care follow-up
  • Caregiver escalation history
  • Vitals and timing context
01 / THE DIAGNOSTIC BLIND SPOT

The drug was right.
The timing wasn’t.

“Yes, doctor. I took all my medicines.”
One answer. Two very different realities.

THE SAME PATIENT. A DIFFERENT PICTURE.
PATIENT A · HYPERTENSION · ILLUSTRATIVE CASE
156/98mmHg
Blood pressureAdherence data unavailable
TREATMENT TIMELINEDay 7 of 7
Day 1Day 4Day 7
WHAT THE CLINICIAN SEES

“The treatment isn’t working.”

Vitals remain elevated. Without timing data, a clinician may consider a higher dose or a stronger medication.

Risk of false treatment failure
Illustrative tilt-sensed dispensing data, not proof of ingestion or clinical guidance. Medication changes require a qualified clinician.
A PRACTICAL EVALUATION PATH

Start small. Define what success means.

01

Define the population

Choose a care program or protocol where dose timing affects decisions.

02

Agree the workflow

Set dose windows, alert recipients, review responsibilities and reporting needs.

03

Review the evidence

Assess usability, missed-window visibility and operational fit before expanding.

Bring adherence into the conversation.
Discuss a pilot, integration needs, or a research partnership.

Discuss a partnership